March 11, 2022
Chugai Pharmaceutical has decided not to appeal a court decision last month that dismissed its claim over a substance patent pertaining to its osteoporosis treatment Edirol (eldecalcitol), a company official told Jiho on March 10. The Tokyo District Court on...read more